Entourage Health Corp. Logo

Entourage Health Corp.

ETRGF

(1.8)
Stock Price

0,00 USD

-182.45% ROA

29.39% ROE

-0.08x PER

Market Cap.

3.578.978,30 USD

-106.34% DER

0% Yield

-107.45% NPM

Entourage Health Corp. Stock Analysis

Entourage Health Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Entourage Health Corp. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (215.97%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-0.04x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-124%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

5 ROA

The stock's ROA (-500.12%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Entourage Health Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Entourage Health Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Entourage Health Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Entourage Health Corp. Revenue
Year Revenue Growth
2014 0
2015 0 0%
2016 353.180 100%
2017 1.451.062 75.66%
2018 7.955.210 81.76%
2019 20.820.180 61.79%
2020 29.433.990 29.26%
2021 42.271.834 30.37%
2022 40.892.068 -3.37%
2023 35.000.412 -16.83%
2023 40.712.982 14.03%
2024 37.052.260 -9.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Entourage Health Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 0 0%
2017 67.461 100%
2018 138.949 51.45%
2019 54.760 -153.74%
2020 834.422 93.44%
2021 396.964 -110.2%
2022 201.607 -96.9%
2023 0 0%
2023 179 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Entourage Health Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 130.820
2015 32.779 -299.1%
2016 98.402 66.69%
2017 6.969.174 98.59%
2018 13.693.762 49.11%
2019 16.408.234 16.54%
2020 26.708.175 38.56%
2021 25.732.854 -3.79%
2022 24.095.144 -6.8%
2023 18.603.468 -29.52%
2023 19.710.939 5.62%
2024 15.652.880 -25.93%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Entourage Health Corp. EBITDA
Year EBITDA Growth
2014 -130.820
2015 -32.779 -299.1%
2016 -98.402 66.69%
2017 -6.783.831 98.55%
2018 -9.270.324 26.82%
2019 -6.151.167 -50.71%
2020 -45.260.163 86.41%
2021 -29.141.628 -55.31%
2022 -46.389.304 37.18%
2023 -13.355.124 -247.35%
2023 -19.259.210 30.66%
2024 -13.541.640 -42.22%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Entourage Health Corp. Gross Profit
Year Gross Profit Growth
2014 0
2015 0 0%
2016 176.590 100%
2017 249.898 29.34%
2018 4.634.039 94.61%
2019 14.871.968 68.84%
2020 -24.205.579 161.44%
2021 -11.714.922 -106.62%
2022 -19.890.954 41.1%
2023 9.756.636 303.87%
2023 5.439.447 -79.37%
2024 4.712.444 -15.43%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Entourage Health Corp. Net Profit
Year Net Profit Growth
2014 -130.820
2015 -32.779 -299.1%
2016 -98.402 66.69%
2017 -8.805.222 98.88%
2018 -895.128 -883.68%
2019 -11.490.217 92.21%
2020 -99.494.090 88.45%
2021 -95.669.342 -4%
2022 -176.861.559 45.91%
2023 -39.620.324 -346.39%
2023 -46.168.010 14.18%
2024 -41.299.808 -11.79%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Entourage Health Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -1 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Entourage Health Corp. Free Cashflow
Year Free Cashflow Growth
2014 -1.389.733
2015 -335.907 -313.73%
2016 -401.692 16.38%
2017 -6.556.013 93.87%
2018 -37.091.263 82.32%
2019 -63.653.317 41.73%
2020 -37.078.830 -71.67%
2021 -30.509.949 -21.53%
2022 -31.863.354 4.25%
2023 -63.952 -49723.86%
2023 -12.719.324 99.5%
2024 -6.786.746 -87.41%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Entourage Health Corp. Operating Cashflow
Year Operating Cashflow Growth
2014 -38.321
2015 -29.924 -28.06%
2016 -88.187 66.07%
2017 -2.986.928 97.05%
2018 -615.514 -385.27%
2019 -7.160.606 91.4%
2020 -35.538.706 79.85%
2021 -30.007.076 -18.43%
2022 -30.166.386 0.53%
2023 849.548 3650.87%
2023 -11.520.265 107.37%
2024 -6.454.621 -78.48%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Entourage Health Corp. Capital Expenditure
Year Capital Expenditure Growth
2014 1.351.412
2015 305.983 -341.66%
2016 313.505 2.4%
2017 3.569.085 91.22%
2018 36.475.749 90.22%
2019 56.492.711 35.43%
2020 1.540.124 -3568.06%
2021 502.873 -206.27%
2022 1.696.968 70.37%
2023 913.500 -85.77%
2023 1.199.059 23.82%
2024 332.125 -261.03%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Entourage Health Corp. Equity
Year Equity Growth
2014 696.924
2015 664.145 -4.94%
2016 620.553 -7.02%
2017 25.132.548 97.53%
2018 77.092.317 67.4%
2019 136.059.185 43.34%
2020 74.090.030 -83.64%
2021 21.426.011 -245.79%
2022 -101.238.935 121.16%
2023 -129.975.348 22.11%
2023 -147.294.652 11.76%
2024 -163.859.498 10.11%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Entourage Health Corp. Assets
Year Assets Growth
2014 706.923
2015 676.999 -4.42%
2016 643.622 -5.19%
2017 39.605.187 98.37%
2018 88.068.657 55.03%
2019 209.798.741 58.02%
2020 171.329.357 -22.45%
2021 144.223.828 -18.79%
2022 46.466.628 -210.38%
2023 38.799.774 -19.76%
2023 31.392.734 -23.59%
2024 23.949.948 -31.08%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Entourage Health Corp. Liabilities
Year Liabilities Growth
2014 9.999
2015 12.854 22.21%
2016 23.069 44.28%
2017 14.472.639 99.84%
2018 10.976.340 -31.85%
2019 73.739.556 85.11%
2020 97.239.327 24.17%
2021 122.797.817 20.81%
2022 147.705.563 16.86%
2023 168.775.122 12.48%
2023 178.687.386 5.55%
2024 187.809.446 4.86%

Entourage Health Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.13
Net Income per Share
-0.14
Price to Earning Ratio
-0.08x
Price To Sales Ratio
0.09x
POCF Ratio
-0.63
PFCF Ratio
-0.5
Price to Book Ratio
-0.02
EV to Sales
4.32
EV Over EBITDA
-11.88
EV to Operating CashFlow
-31.1
EV to FreeCashFlow
-24.54
Earnings Yield
-12.21
FreeCashFlow Yield
-2
Market Cap
0,00 Bil.
Enterprise Value
0,18 Bil.
Graham Number
1.3
Graham NetNet
-0.57

Income Statement Metrics

Net Income per Share
-0.14
Income Quality
0.13
ROE
0.29
Return On Assets
-1.82
Return On Capital Employed
0.1
Net Income per EBT
1
EBT Per Ebit
2.85
Ebit per Revenue
-0.38
Effective Tax Rate
-0.38

Margins

Sales, General, & Administrative to Revenue
0.43
Research & Developement to Revenue
-0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.13
Operating Profit Margin
-0.38
Pretax Profit Margin
-1.07
Net Profit Margin
-1.07

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.02
Free CashFlow per Share
-0.02
Capex to Operating CashFlow
-0.27
Capex to Revenue
0.04
Capex to Depreciation
2.77
Return on Invested Capital
-2.04
Return on Tangible Assets
-1.82
Days Sales Outstanding
28.47
Days Payables Outstanding
31.03
Days of Inventory on Hand
114.78
Receivables Turnover
12.82
Payables Turnover
11.76
Inventory Turnover
3.18
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
-0,53
Tangible Book Value per Share
-0.53
Shareholders Equity per Share
-0.53
Interest Debt per Share
0.65
Debt to Equity
-1.06
Debt to Assets
7.28
Net Debt to EBITDA
-11.64
Current Ratio
0.1
Tangible Asset Value
-0,16 Bil.
Net Current Asset Value
-0,17 Bil.
Invested Capital
-158733088
Working Capital
-0,16 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
11041119
Debt to Market Cap
48.68

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Entourage Health Corp. Dividends
Year Dividends Growth

Entourage Health Corp. Profile

About Entourage Health Corp.

Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. The company offers cannabis plants, dried cannabis, oils, topicals, extracts, and edibles. It provides its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinals, and Mary's Medicinals brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Toronto, Canada.

CEO
Mr. George Scorsis
Employee
0
Address
276 Queen Street West
Toronto, M5V 2A1

Entourage Health Corp. Executives & BODs

Entourage Health Corp. Executives & BODs
# Name Age
1 Mr. James Afara
Chief Operating Officer
70
2 Pat Scanlon
Head of Cultivation
70
3 Dr. Alexandre Sibilev
Vice-President of Quality Assurance & Global Regulatory Compliance
70
4 Ms. Vaani Maharaj
Chief Financial Officer
70
5 Mr. Jeff Keyes
Senior Vice President of Operations
70
6 Catherine Flaman
Senior Director of Communications & Corporate Affairs
70
7 Mr. Joseph Mele
Chief Commercial Officer
70
8 Dr. Peter Blecher
Chief Medical Officer
70
9 Ms. Marianella DelaBarrera
Senior Vice President of Communications & Corporate Affairs
70
10 Mr. George Scorsis
Executive Chair & Chief Executive Officer
70

Entourage Health Corp. Competitors